{"entity":{"type":"insider","cik":"0001848372","url":"/insider/0001848372","json_url":"/insider/0001848372.json","name":"William Arsani","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":7,"first":"2021-04-01","last":"2025-08-14","span_basis":"filed_date"},"name_variants":[{"name":"William Arsani","source":"filing","n_filings":7,"first_seen":"2021-04-01","last_seen":"2025-08-14"}],"transactions":[{"id":4467517,"accession":"0001415889-25-021842","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021842","line_url":"/filing/0001415889-25-021842","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562627.0,"shares_display":"562,627","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":2953791.75,"total_display":"2,953,791.75","total_whole":"2,953,792","shares_owned_after":2655000.0,"shares_owned_after_display":"2,655,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider","n_lines":2},{"id":2807048,"accession":"0001415889-24-021086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-021086","line_url":"/filing/0001415889-24-021086#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":814874.0,"shares_display":"814,874","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":3463214.5,"total_display":"3,463,214.50","total_whole":"3,463,215","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-12","scope":"insider"},{"id":8630265,"accession":"0001209191-23-047773","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-047773","line_url":"/filing/0001209191-23-047773#line-2","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1960000.0,"shares_display":"1,960,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":4782400.0,"total_display":"4,782,400.00","total_whole":"4,782,400","shares_owned_after":3000000.0,"shares_owned_after_display":"3,000,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-29","filed_date":"2023-08-30","scope":"insider"},{"id":8630262,"accession":"0001209191-23-047773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047773","line_url":"/filing/0001209191-23-047773#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":591250.0,"total_display":"591,250.00","total_whole":"591,250","shares_owned_after":1040000.0,"shares_owned_after_display":"1,040,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":6428914,"accession":"0001209191-22-020638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-020638","line_url":"/filing/0001209191-22-020638#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":18.9872,"price_display":"18.99","price_state":"stated","total_value":474680.0,"total_display":"474,680.00","total_whole":"474,680","shares_owned_after":2797501.0,"shares_owned_after_display":"2,797,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-22","scope":"insider"},{"id":4792934,"accession":"0001209191-21-054492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-054492","line_url":"/filing/0001209191-21-054492#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":15.45,"price_display":"15.45","price_state":"stated","total_value":618000.0,"total_display":"618,000.00","total_whole":"618,000","shares_owned_after":2772501.0,"shares_owned_after_display":"2,772,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-31","filed_date":"2021-09-02","scope":"insider"},{"id":9272056,"accession":"0001209191-23-048441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048441","line_url":"/filing/0001209191-23-048441#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":14000000.0,"total_display":"14,000,000.00","total_whole":"14,000,000","shares_owned_after":700000.0,"shares_owned_after_display":"700,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2023-09-06","scope":"insider"},{"id":5193033,"accession":"0001209191-21-024224","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-024224","line_url":"/filing/0001209191-21-024224#line-3","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":"0001848372","owner_name":"William Arsani","owner_display_name":"William Arsani","owner_url":"/insider/0001848372","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":14000000.0,"total_display":"14,000,000.00","total_whole":"14,000,000","shares_owned_after":2732501.0,"shares_owned_after_display":"2,732,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Director","n_filings":7,"first_seen":"2021-04-01","last_seen":"2025-08-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001848372","retrieved_at":"2026-08-27T08:38:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}